| |
| |
|
| Insider
Information: |
Greene Gabrielle E |
| Relationship: |
Director |
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
191,878 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,298,814 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
191,878 |
|
|
| Total
Value |
$7,298,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 126.5%
|
 -74.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Whole Foods Market Inc |
WFM |
Director |
2017-08-28 |
0 |
2004-08-05 |
0 |
Premium* |
|
|
IndyMac Bancorp Inc |
IDMCQ |
Director, IndyMac Bank... |
2008-03-19 |
4,443 |
2007-01-23 |
0 |
Premium* |
|
|
Stage Stores Inc |
SSI |
Director |
2014-06-10 |
26,729 |
|
0 |
Premium* |
|
|
Brixmor Property Group Inc. |
BRX |
Director |
2021-06-01 |
37,161 |
|
0 |
Premium* |
|
|
MasterCard Inc A |
MA |
Director |
2023-06-27 |
4,333 |
2018-12-03 |
0 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2023-06-07 |
47,853 |
|
0 |
Premium* |
|
|
Warby Parker Inc. |
WRBY |
Director |
2023-06-08 |
69,231 |
|
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Director |
2024-04-15 |
2,128 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-04-15 |
4 |
A |
$750.77 |
$9,760 |
D/D |
13 |
2,128 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-03-18 |
4 |
A |
$762.66 |
$9,915 |
D/D |
13 |
2,115 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-02-20 |
4 |
A |
$755.66 |
$9,824 |
D/D |
13 |
2,098 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2024-01-16 |
4 |
A |
$634.57 |
$10,153 |
D/D |
16 |
2,085 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-12-18 |
4 |
A |
$579.76 |
$5,218 |
D/D |
9 |
2,069 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-11-20 |
4 |
A |
$597.60 |
$204,977 |
D/D |
343 |
2,057 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-10-16 |
4 |
A |
$616.64 |
$4,933 |
D/D |
8 |
1,714 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-09-18 |
4 |
A |
$571.28 |
$5,142 |
D/D |
9 |
1,706 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-08-21 |
4 |
A |
$550.50 |
$4,955 |
D/D |
9 |
1,694 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-07-17 |
4 |
A |
$447.14 |
$4,919 |
D/D |
11 |
1,685 |
0 |
- |
|
| MA |
MasterCard Inc A |
Director |
– • – |
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
642 |
4,333 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-06-20 |
4 |
A |
$451.95 |
$4,971 |
D/D |
11 |
1,674 |
0 |
- |
|
| WRBY |
Warby Parker Inc. |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
23,116 |
69,231 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,282 |
47,853 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-05-15 |
4 |
A |
$434.51 |
$4,780 |
D/D |
11 |
1,659 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-04-17 |
4 |
A |
$372.35 |
$4,841 |
D/D |
13 |
1,648 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-03-20 |
4 |
A |
$333.60 |
$5,004 |
D/D |
15 |
1,635 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-02-21 |
4 |
A |
$327.51 |
$4,913 |
D/D |
15 |
1,614 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2023-01-17 |
4 |
A |
$357.74 |
$5,008 |
D/D |
14 |
1,599 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-12-19 |
4 |
A |
$357.78 |
$10,018 |
D/D |
28 |
1,585 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-11-21 |
4 |
A |
$361.17 |
$189,614 |
D/D |
525 |
1,554 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-10-17 |
4 |
A |
$332.76 |
$9,983 |
D/D |
30 |
1,029 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-09-19 |
4 |
A |
$305.09 |
$10,068 |
D/D |
33 |
999 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-08-15 |
4 |
A |
$313.94 |
$10,046 |
D/D |
32 |
963 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
931 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
